We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Lenograstim prevents morbidity from intensive induction chemotherapy in the treatment of inflammatory breast cancer.
- Authors
Chevallier, B; Chollet, P; Merrouche, Y; Roche, H; Fumoleau, P; Kerbrat, P; Genot, J Y; Fargeot, P; Olivier, J P; Fizames, C
- Abstract
To compare the efficacy and safety of recombinant human granulocyte colony-stimulating factor (rHuG-CSF) versus its inert vehicle in patients with unilateral nonmetastatic inflammatory breast cancer treated with fluorouracil, epirubicin, and cyclophosphamide high-dose (FEC-HD) neoadjuvant chemotherapy.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Vol 13, Issue 7, p1564
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.1995.13.7.1564